Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 450 of 499 entries
View as:

REGEND001 Autologous Basal Layer Stem Cell Transplantation for Bronchiectasis: A Translational Application Study

Phase: N/A Priority: Normal
NCT ID: NCT06987214 Org: User:
Start: 06/30/25 End: 05/30/26 Due: 05/30/27

Inaticabtagene Autoleucel (Inati-cel; CNCT19) Treatment for MRD-Positive B-ALL Patients in CR1

Phase: N/A Priority: Normal
NCT ID: NCT06718244 Org: User:
Start: 12/10/24 End: 12/31/29 Due: 12/31/30

Mechanism Investigation of R-CHOP Regimen or Tucidinostat Plus R-CHOP (CR-CHOP) Regimen in the Treatment of BCL2/MYC Protein Double Expressor Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT06652152 Org: User:
Start: 10/30/24 End: 12/30/25 Due: 12/30/26

PD-1 Inhibitor Tislelizumab Maintenance Therapy in Newly Diagnosed DLBCL Patients After ASCT

Phase: N/A Priority: Normal
NCT ID: NCT04789434 Org: User:
Start: 07/09/21 End: 07/01/24 Due: 07/01/25

Using Cryoballoon Ablation as Initial Treatment for Persistent Atrial Fibrillation

Phase: N/A Priority: Normal
NCT ID: NCT04942834 Org: User:
Start: 10/01/21 End: 01/31/26 Due: 01/31/27

The Combination of PSMA-PET/MR and p2PSA in Early Diagnosis of Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05822726 Org: User:
Start: 10/01/22 End: 06/30/25 Due: 06/30/26

Tumor Microenvironment Mechanism of LY007 for r/r B-NHL and the Exploration of Novel CAR-T Translational Research

Phase: N/A Priority: Normal
NCT ID: NCT06049381 Org: User:
Start: 10/01/23 End: 12/31/25 Due: 12/31/26

Influence of Shenqu Xiaoshi Oral Liquid on Intestinal Microbiome of Children With Functional Dyspepsia

Phase: N/A Priority: Normal
NCT ID: NCT05515887 Org: User:
Start: 11/22/22 End: 03/31/25 Due: 03/31/26

PRP vs PRP+IVC for Severe nPDR

Phase: N/A Priority: Normal
NCT ID: NCT03863535 Org: User:
Start: 01/18/19 End: 09/30/21 Due: 09/30/22

The Link Between the Clinical Resting Heart Rate and Sympathetic Overactivation

Phase: N/A Priority: Normal
NCT ID: NCT02315313 Org: User:
Start: 12/31/14 End: - Due: -

3D Reconstruction in Video-assisted Thoracoscopic Surgery (VATS) Segmentectomy

Phase: N/A Priority: Normal
NCT ID: NCT04004494 Org: User:
Start: 07/01/19 End: 12/31/23 Due: 12/31/24

Bronchoscopic Navigation Robot-guided Dye Marking-assisted Thoracoscopic Pulmonary Nodule Resection

Phase: N/A Priority: Normal
NCT ID: NCT06821451 Org: User:
Start: 02/10/25 End: 03/31/26 Due: 03/31/27

Clinical Analysis of the Antihypertensive Effect of Laparoscopic Peripheral Nerve Blockade of the Renal Artery in Patients With Retroperitoneal Disease and Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT06829134 Org: User:
Start: 03/01/25 End: 12/01/26 Due: 12/01/27

Pulmonary Resectable Osteosarcoma Treated by Metastasectomy and Pre-operative Immunotherapy and Stereotactic Body Radiotherapy (PROMIS): a Prospective Clinical Trial

Phase: N/A Priority: Normal
NCT ID: NCT06114225 Org: User:
Start: 06/01/23 End: 12/30/26 Due: 12/30/27

Study on the Safety and Tolerability of PD-1 Knockout Tumor-infiltrating T Cells (TILs) in the Treatment of Advanced Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT07035002 Org: User:
Start: 12/31/24 End: 12/31/26 Due: 12/31/27

Molecular Genetics Guide the Maintenance Therapy After Allogeneic Hematopoietic Stem Cell Transplantation

Phase: N/A Priority: Normal
NCT ID: NCT06972641 Org: User:
Start: 06/10/25 End: 03/31/30 Due: 03/31/31

12-Month Real-World Safety & Efficacy of Lecanemab in Early Alzheimer's Disease

Phase: N/A Priority: Normal
NCT ID: NCT07034222 Org: User:
Start: 02/01/24 End: 01/01/26 Due: 01/01/27

Anti-PD-1 Antibody Combined With Pegaspargase in the Treatment of Advanced Stage NK/T-cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT04096690 Org: User:
Start: 09/10/19 End: 12/31/22 Due: 12/31/23

A Retrospective Study on Extranodal Lymphoma or Lymphoma of Rare Pathological Types

Phase: N/A Priority: Normal
NCT ID: NCT05907447 Org: User:
Start: 07/01/23 End: 10/01/24 Due: 10/01/25

The Role of 18F-FDG and 68Ga-FAPI PET/CT in the Diagnosis and the Efficacy Evaluation of Advanced Colorectal Cancer (peritoneal Metastasis With/without Other Metastases)

Phase: N/A Priority: Normal
NCT ID: NCT06601075 Org: User:
Start: 02/01/25 End: 03/31/29 Due: 03/31/30

Precision Regional Node Irradiation for Sentinel Node-positive Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06583655 Org: User:
Start: 03/01/24 End: 06/30/26 Due: 06/30/27

Antithrombotic Therapy With Regulation of Blood Pressure in Non-Cardioembolic Progressive Stroke

Phase: N/A Priority: Normal
NCT ID: NCT06551727 Org: User:
Start: 08/15/24 End: 07/31/25 Due: 07/31/26

Characteristics of Intestinal Bacteria and Their Effects on Growth and Immune Function in Children at High Altitude

Phase: N/A Priority: Normal
NCT ID: NCT06157346 Org: User:
Start: 10/16/23 End: 08/31/26 Due: 08/31/27

Mutant p53-based Personalized Trial Using Decitabine and Arsenic Trioxide on AML/MDS

Phase: N/A Priority: Normal
NCT ID: NCT03855371 Org: User:
Start: 01/10/18 End: 07/31/24 Due: 07/31/25

An Evaluation of LY007 Cell Injection for r/r B-NHL

Phase: N/A Priority: Normal
NCT ID: NCT06364852 Org: User:
Start: 12/25/21 End: 05/31/26 Due: 05/31/27